Oral PrEP will reach women who need it if PrEP programs are well-supported and prepared. A collaboration between LVCT Health in Kenya and AVAC, through the USAID-funded OPTIONS Consortium, this video series shows how LVCT Health made changes at the site level and helped women interested in oral PrEP overcome recurring barriers to uptake and adherence.
Each film in the series highlights a different theme or challenge that emerged as PrEP rolled out, and tells the story of how the project responded–and has an accompanying commentary as well. This series is intended to foster innovation and problem-solving among key PrEP stakeholders, including program implementers, policy makers, civil society, advocates and people considering PrEP.
Issue: Women find it difficult to come to a clinic for oral PrEP services because of stigma. Additionally, taking
medicine for prevention is not a common practice.
Key Findings: Testing in the community, reaching women where they access family planning or other services,
and peer to peer encouragement increased the number of women accessing oral PrEP.
Issue: Women are more likely to start and continue oral PrEP if clinics offer an accommodating and welcoming
Key Findings: Integrated services, sensitized staff, adjusted clinic hours, support groups and hotline numbers
encouraged women to take up and stay on oral PrEP.
Issue: Women who begin oral PrEP often do not continue after the first month due to side effects, stigma, and the burden of a daily pill.
Key Findings: Programs can minimize drop off during month one with continuous communication, easy access to staff and support groups.
Issue: Men often have the power to decide if a woman uses oral PrEP.
Key Findings: Programs trying to reach women need to actively engage men who act as “gatekeepers” for women considering starting oral PrEP.
There’s no question that a simple regimen of a single daily pill can slash HIV infections in people at risk. But although millions of people around the world could benefit, only 200,000 are prescribed PrEP, and 75 percent of them are in the United States. The disparity was the focus of anguished discussions this week at the largest annual US HIV/AIDS conference.
The Center for AIDS Research at Emory University's Rollins School of Public Health produces interactive online maps with visualized data on different aspects of the US HIV epidemic, and its prevention and treatment response, at AIDSVu.org. This set of maps and statistics focuses on PrEP use nationally and by state from 2012-2016.
The International Treatment Preparedness Coalition (ITPC) has released the Key Population Activist Toolkit on PrEP, developed to equip community activists to demand pre-exposure prophylaxis (PrEP). The toolkit includes step by step guidance for activists to develop an advocacy agenda to bring effective PrEP programs to their communities.